Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Trade Fight Widens as Europe and Canada Retaliate Against Trump Tariffs As President Trump’s global tariffs on metals took effect, the European Union and Canada announced billions of dollars in ...

Lily Allen and David Harbour's Raya drama feels like it's straight out of a Netflix thriller, messy, unexpected, and filled ...